{
    "clinical_study": {
        "@rank": "90865", 
        "arm_group": {
            "arm_group_label": "Picosure Laser System", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the PICOSURE Laser System for the treatment of\n      unwanted tattoos"
        }, 
        "brief_title": "Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Unwanted Tattoos", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is a healthy non-smoking (must have quit 6 months prior) male or female between 18\n             and 65 years old.\n\n          2. Is willing to consent to participate in the study.\n\n          3. Is willing to comply with all requirements of the study including being photographed,\n             following post treatment care and attending all treatment and follow up visits\n\n          4. Has unwanted non-cosmetic tattoo containing red ink, that has not previously been\n             treated, and wishes to undergo laser treatment\n\n        Exclusion Criteria:\n\n          1. The subject is female and pregnant, has been pregnant within the last 3 months, is\n             currently breast feeding or planning a pregnancy during the study period.\n\n          2. The subject is hypersensitive to light exposure OR takes photo sensitized medication.\n\n          3. The subject has active or localized systemic infections.\n\n          4. The subject has a coagulation disorder or is currently using anti-coagulation\n             medication (including but not limited to heavy aspirin therapy {greater than 81 mg\n             per day}).\n\n          5. The subject has any condition which, in the investigator's opinion, would make it\n             unsafe for the subject to participate in this research study.\n\n          6. The subject is currently enrolled in an investigational drug or device trial, or has\n             received an investigational drug or been treated with an investigational device\n             within 3 months prior to entering this study.\n\n          7. The subject has used Accutane within 6 months prior to enrollment.\n\n          8. The subject has the need to be exposed to artificial tanning devices or excessive\n             sunlight during the trial.\n\n          9. The subject has had prior treatment with parenteral gold therapy (gold sodium\n             thiomalate).\n\n         10. The subject has a history of keloids.\n\n         11. The subject has evidence of compromised wound healing.\n\n         12. The subject has a history of basal cell carcinoma, squamous cell carcinoma or\n             melanoma.\n\n         13. The subject has a history of immunosuppression/immune deficiency disorders (including\n             HIV infection or AIDS) or use of immunosuppressive medications or has an autoimmune\n             disorder."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103153", 
            "org_study_id": "CYN13-PICO532-RG5"
        }, 
        "intervention": {
            "arm_group_label": "Picosure Laser System", 
            "intervention_name": "Picosure Laser System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10016"
                }, 
                "name": "Laser & Skin Surgery Center of New York"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Compare level of clearance using a photographic scale", 
            "safety_issue": "No", 
            "time_frame": "2 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103153"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Assess Investigator and subject satisfaction by questionnaire", 
            "safety_issue": "No", 
            "time_frame": "2 months post treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}